162 related articles for article (PubMed ID: 34665684)
1. A systematic review and meta-analysis of maintenance treatment for psychotic depression.
Al-Wandi A; Holmberg C; Landén M; Nordenskjöld A
Nord J Psychiatry; 2022 Aug; 76(6):442-450. PubMed ID: 34665684
[TBL] [Abstract][Full Text] [Related]
2. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment.
Farahani A; Correll CU
J Clin Psychiatry; 2012 Apr; 73(4):486-96. PubMed ID: 22579147
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological treatment for psychotic depression.
Wijkstra J; Lijmer J; Burger H; Cipriani A; Geddes J; Nolen WA
Cochrane Database Syst Rev; 2015 Jul; (7):CD004044. PubMed ID: 26225902
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatment for psychotic depression.
Wijkstra J; Lijmer J; Burger H; Geddes J; Nolen WA
Cochrane Database Syst Rev; 2013 Nov; (11):CD004044. PubMed ID: 24282034
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological treatment for psychotic depression.
Wijkstra J; Lijmer J; Balk F; Geddes J; Nolen WA
Cochrane Database Syst Rev; 2005 Oct; (4):CD004044. PubMed ID: 16235348
[TBL] [Abstract][Full Text] [Related]
6. Medication Adherence and Persistence in Patients with Severe Major Depressive Disorder with Psychotic Features: Antidepressant and Second-Generation Antipsychotic Therapy Versus Antidepressant Monotherapy.
Kim-Romo DN; Rascati KL; Richards KM; Ford KC; Wilson JP; Beretvas SN
J Manag Care Spec Pharm; 2016 May; 22(5):588-96. PubMed ID: 27123919
[TBL] [Abstract][Full Text] [Related]
7. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
[TBL] [Abstract][Full Text] [Related]
8. Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy.
Ogawa Y; Tajika A; Takeshima N; Hayasaka Y; Furukawa TA
CNS Drugs; 2014 Nov; 28(11):989-1003. PubMed ID: 25160685
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis.
Wijkstra J; Lijmer J; Balk FJ; Geddes JR; Nolen WA
Br J Psychiatry; 2006 May; 188():410-5. PubMed ID: 16648526
[TBL] [Abstract][Full Text] [Related]
10. Challenges in the treatment of major depressive disorder with psychotic features.
Rothschild AJ
Schizophr Bull; 2013 Jul; 39(4):787-96. PubMed ID: 23599251
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotics in the maintenance phase for psychotic depression.
Al-Wandi A; Landén M; Nordenskjöld A
Acta Psychiatr Scand; 2024 Jan; 149(1):6-17. PubMed ID: 37932158
[TBL] [Abstract][Full Text] [Related]
12. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
13. The Korean Medication Algorithm for Depressive Disorder: second revision.
Seok Seo J; Rim Song H; Bin Lee H; Park YM; Hong JW; Kim W; Wang HR; Lim ES; Jeong JH; Jon DI; Joon Min K; Sup Woo Y; Bahk WM
J Affect Disord; 2014; 167():312-21. PubMed ID: 25010375
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
[TBL] [Abstract][Full Text] [Related]
15. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
Goss AJ; Kaser M; Costafreda SG; Sahakian BJ; Fu CH
J Clin Psychiatry; 2013 Nov; 74(11):1101-7. PubMed ID: 24330897
[TBL] [Abstract][Full Text] [Related]
16. Psychotic depression--beyond the antidepressant/antipsychotic combination.
Nelson EB
Curr Psychiatry Rep; 2012 Dec; 14(6):619-23. PubMed ID: 22936518
[TBL] [Abstract][Full Text] [Related]
17. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
Papakostas GI; Martinson MA; Fava M; Iovieno N
J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
[TBL] [Abstract][Full Text] [Related]
18. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
[TBL] [Abstract][Full Text] [Related]
19. [Systematic review to evaluate the efficacy, acceptability and safety of second-generation antipsychotics for the treatment of unipolar and bipolar depression.].
Amato L; Vecchi S; Barbui C; Cruciani F; D'Amico R; Del Giovane C; Minozzi S; Mitrova Z; Saulle R; Davoli M
Recenti Prog Med; 2018 Oct; 109(10):474-486. PubMed ID: 30394408
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials.
Faridhosseini F; Sadeghi R; Farid L; Pourgholami M
Hum Psychopharmacol; 2014 May; 29(3):216-23. PubMed ID: 24911574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
